ID   ZFY21_HUMAN             Reviewed;         234 AA.
AC   Q9BQ24; A8K3A4; Q86T05; Q96LT1;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-JUN-2023, entry version 156.
DE   RecName: Full=Zinc finger FYVE domain-containing protein 21;
DE            Short=ZF21;
GN   Name=ZFYVE21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zheng H., Xie Y., Mao Y.;
RT   "Cloning of a FYVE containing protein.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH PTK2/FAK1, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF 64-HIS-HIS-65.
RX   PubMed=20439989; DOI=10.1074/jbc.m110.106443;
RA   Nagano M., Hoshino D., Sakamoto T., Kawasaki N., Koshikawa N., Seiki M.;
RT   "ZF21 protein regulates cell adhesion and motility.";
RL   J. Biol. Chem. 285:21013-21022(2010).
RN   [7]
RP   STRUCTURE BY NMR OF 107-234, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   PH-LIKE DOMAIN.
RX   PubMed=21768110; DOI=10.1074/jbc.m110.199430;
RA   Nagano M., Hoshino D., Koshiba S., Shuo T., Koshikawa N., Tomizawa T.,
RA   Hayashi F., Tochio N., Harada T., Akizawa T., Watanabe S., Handa N.,
RA   Shirouzu M., Kigawa T., Yokoyama S., Seiki M.;
RT   "ZF21 protein, a regulator of the disassembly of focal adhesions and cancer
RT   metastasis, contains a novel noncanonical pleckstrin homology domain.";
RL   J. Biol. Chem. 286:31598-31609(2011).
CC   -!- FUNCTION: Plays a role in cell adhesion, and thereby in cell motility
CC       which requires repeated formation and disassembly of focal adhesions.
CC       Regulates microtubule-induced PTK2/FAK1 dephosphorylation, an event
CC       important for focal adhesion disassembly, as well as integrin beta-
CC       1/ITGB1 cell surface expression. {ECO:0000269|PubMed:20439989,
CC       ECO:0000269|PubMed:21768110}.
CC   -!- SUBUNIT: Interacts with PTK2/FAK1. {ECO:0000269|PubMed:20439989,
CC       ECO:0000269|PubMed:21768110}.
CC   -!- INTERACTION:
CC       Q9BQ24; Q6RW13: AGTRAP; NbExp=3; IntAct=EBI-2849569, EBI-741181;
CC       Q9BQ24; Q15041: ARL6IP1; NbExp=6; IntAct=EBI-2849569, EBI-714543;
CC       Q9BQ24; Q8IZR5-2: CMTM4; NbExp=3; IntAct=EBI-2849569, EBI-17278014;
CC       Q9BQ24; Q5SUL5: HLA-A; NbExp=3; IntAct=EBI-2849569, EBI-8561769;
CC       Q9BQ24; Q92993: KAT5; NbExp=3; IntAct=EBI-2849569, EBI-399080;
CC       Q9BQ24; Q15323: KRT31; NbExp=3; IntAct=EBI-2849569, EBI-948001;
CC       Q9BQ24; O76015: KRT38; NbExp=3; IntAct=EBI-2849569, EBI-1047263;
CC       Q9BQ24; Q6A162: KRT40; NbExp=3; IntAct=EBI-2849569, EBI-10171697;
CC       Q9BQ24; P60370: KRTAP10-5; NbExp=3; IntAct=EBI-2849569, EBI-10172150;
CC       Q9BQ24; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-2849569, EBI-10171774;
CC       Q9BQ24; P26371: KRTAP5-9; NbExp=3; IntAct=EBI-2849569, EBI-3958099;
CC       Q9BQ24; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-2849569, EBI-11742507;
CC       Q9BQ24; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-2849569, EBI-10172526;
CC       Q9BQ24; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-2849569, EBI-742948;
CC       Q9BQ24; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-2849569, EBI-945833;
CC       Q9BQ24; Q5VU43: PDE4DIP; NbExp=3; IntAct=EBI-2849569, EBI-1105124;
CC       Q9BQ24; P17252: PRKCA; NbExp=3; IntAct=EBI-2849569, EBI-1383528;
CC       Q9BQ24; Q9UI14: RABAC1; NbExp=6; IntAct=EBI-2849569, EBI-712367;
CC       Q9BQ24; Q96HR9: REEP6; NbExp=3; IntAct=EBI-2849569, EBI-750345;
CC       Q9BQ24; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-2849569, EBI-14065960;
CC       Q9BQ24; Q9NQC3: RTN4; NbExp=3; IntAct=EBI-2849569, EBI-715945;
CC       Q9BQ24; Q9NQC3-2: RTN4; NbExp=3; IntAct=EBI-2849569, EBI-10296096;
CC       Q9BQ24; Q15047-2: SETDB1; NbExp=3; IntAct=EBI-2849569, EBI-9090795;
CC       Q9BQ24; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-2849569, EBI-747107;
CC       Q9BQ24; Q71RC9: SMIM5; NbExp=3; IntAct=EBI-2849569, EBI-12334905;
CC       Q9BQ24; Q13077: TRAF1; NbExp=3; IntAct=EBI-2849569, EBI-359224;
CC       Q9BQ24; P14373: TRIM27; NbExp=3; IntAct=EBI-2849569, EBI-719493;
CC       Q9BQ24; O95070: YIF1A; NbExp=3; IntAct=EBI-2849569, EBI-2799703;
CC       Q9BQ24; P61981: YWHAG; NbExp=3; IntAct=EBI-2849569, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion. Cytoplasmic
CC       vesicle. Endosome. Note=Within cytoplasmic vesicles, partially
CC       colocalizes with EEA1, an endosomal marker.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BQ24-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BQ24-2; Sequence=VSP_013794;
CC   -!- DOMAIN: The FYVE-type zinc finger mediates interaction with PTK2/FAK1,
CC       and also interaction with PI(3)P and association with endosomes.
CC   -!- DOMAIN: The C-terminal region exhibits a structure similar to canonical
CC       PH domains, but lacks a positively charged interface to bind
CC       phosphatidylinositol phosphate.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62589.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY395756; AAR14313.1; -; mRNA.
DR   EMBL; BX248261; CAD62589.1; ALT_INIT; mRNA.
DR   EMBL; AK057816; BAB71589.1; -; mRNA.
DR   EMBL; AK290519; BAF83208.1; -; mRNA.
DR   EMBL; CH471061; EAW81844.1; -; Genomic_DNA.
DR   EMBL; BC001130; AAH01130.1; -; mRNA.
DR   EMBL; BC005999; AAH05999.1; -; mRNA.
DR   CCDS; CCDS55948.1; -. [Q9BQ24-2]
DR   CCDS; CCDS9985.1; -. [Q9BQ24-1]
DR   RefSeq; NP_001185882.1; NM_001198953.1. [Q9BQ24-2]
DR   RefSeq; NP_076976.1; NM_024071.3. [Q9BQ24-1]
DR   PDB; 2RRF; NMR; -; A=107-234.
DR   PDBsum; 2RRF; -.
DR   AlphaFoldDB; Q9BQ24; -.
DR   BMRB; Q9BQ24; -.
DR   SMR; Q9BQ24; -.
DR   BioGRID; 122502; 85.
DR   IntAct; Q9BQ24; 34.
DR   STRING; 9606.ENSP00000216602; -.
DR   iPTMnet; Q9BQ24; -.
DR   PhosphoSitePlus; Q9BQ24; -.
DR   BioMuta; ZFYVE21; -.
DR   DMDM; 66774028; -.
DR   EPD; Q9BQ24; -.
DR   jPOST; Q9BQ24; -.
DR   MassIVE; Q9BQ24; -.
DR   MaxQB; Q9BQ24; -.
DR   PeptideAtlas; Q9BQ24; -.
DR   ProteomicsDB; 78615; -. [Q9BQ24-1]
DR   ProteomicsDB; 78616; -. [Q9BQ24-2]
DR   Antibodypedia; 28114; 125 antibodies from 23 providers.
DR   DNASU; 79038; -.
DR   Ensembl; ENST00000216602.10; ENSP00000216602.6; ENSG00000100711.14. [Q9BQ24-2]
DR   Ensembl; ENST00000311141.7; ENSP00000310543.2; ENSG00000100711.14. [Q9BQ24-1]
DR   GeneID; 79038; -.
DR   KEGG; hsa:79038; -.
DR   MANE-Select; ENST00000311141.7; ENSP00000310543.2; NM_024071.4; NP_076976.1.
DR   UCSC; uc001yoc.4; human. [Q9BQ24-1]
DR   AGR; HGNC:20760; -.
DR   CTD; 79038; -.
DR   DisGeNET; 79038; -.
DR   GeneCards; ZFYVE21; -.
DR   HGNC; HGNC:20760; ZFYVE21.
DR   HPA; ENSG00000100711; Low tissue specificity.
DR   MIM; 613504; gene.
DR   neXtProt; NX_Q9BQ24; -.
DR   OpenTargets; ENSG00000100711; -.
DR   PharmGKB; PA134879875; -.
DR   VEuPathDB; HostDB:ENSG00000100711; -.
DR   eggNOG; ENOG502QRR6; Eukaryota.
DR   GeneTree; ENSGT00940000159639; -.
DR   HOGENOM; CLU_103398_0_0_1; -.
DR   InParanoid; Q9BQ24; -.
DR   OMA; KRPAAAW; -.
DR   OrthoDB; 38671at2759; -.
DR   PhylomeDB; Q9BQ24; -.
DR   TreeFam; TF329481; -.
DR   PathwayCommons; Q9BQ24; -.
DR   SignaLink; Q9BQ24; -.
DR   BioGRID-ORCS; 79038; 12 hits in 1159 CRISPR screens.
DR   ChiTaRS; ZFYVE21; human.
DR   EvolutionaryTrace; Q9BQ24; -.
DR   GenomeRNAi; 79038; -.
DR   Pharos; Q9BQ24; Tbio.
DR   PRO; PR:Q9BQ24; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9BQ24; protein.
DR   Bgee; ENSG00000100711; Expressed in secondary oocyte and 190 other tissues.
DR   ExpressionAtlas; Q9BQ24; baseline and differential.
DR   Genevisible; Q9BQ24; HS.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   CDD; cd15727; FYVE_ZF21; 1.
DR   Gene3D; 2.30.29.160; Zinc finger FYVE domain-containing protein 21, C-terminal; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR032031; ZFYVE21_C.
DR   InterPro; IPR038632; ZFYVE21_C_sf.
DR   InterPro; IPR000306; Znf_FYVE.
DR   InterPro; IPR017455; Znf_FYVE-rel.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR39490; ARRESTIN DOMAIN-CONTAINING PROTEIN D; 1.
DR   PANTHER; PTHR39490:SF8; ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 21; 1.
DR   Pfam; PF01363; FYVE; 1.
DR   Pfam; PF16696; ZFYVE21_C; 1.
DR   SMART; SM00064; FYVE; 1.
DR   SUPFAM; SSF57903; FYVE/PHD zinc finger; 1.
DR   PROSITE; PS50178; ZF_FYVE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cytoplasmic vesicle;
KW   Endosome; Metal-binding; Reference proteome; Zinc; Zinc-finger.
FT   CHAIN           1..234
FT                   /note="Zinc finger FYVE domain-containing protein 21"
FT                   /id="PRO_0000098720"
FT   ZN_FING         44..104
FT                   /note="FYVE-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   REGION          107..234
FT                   /note="PH-like"
FT   BINDING         50
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         53
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         66
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         69
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         74
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         77
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         96
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         99
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   VAR_SEQ         175
FT                   /note="G -> GEKDIHAYTSLRGSQPASE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013794"
FT   MUTAGEN         64..65
FT                   /note="HH->NN: Diffuse cytoplasmic localization."
FT                   /evidence="ECO:0000269|PubMed:20439989"
FT   HELIX           108..119
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          134..140
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          144..158
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   TURN            159..161
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          174..178
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          185..188
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          197..202
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   STRAND          206..208
FT                   /evidence="ECO:0007829|PDB:2RRF"
FT   HELIX           211..230
FT                   /evidence="ECO:0007829|PDB:2RRF"
SQ   SEQUENCE   234 AA;  26506 MW;  AF8C695D2417FE98 CRC64;
     MSSEVSARRD AKKLVRSPSG LRMVPEHRAF GSPFGLEEPQ WVPDKECRRC MQCDAKFDFL
     TRKHHCRRCG KCFCDRCCSQ KVPLRRMCFV DPVRQCAECA LVSLKEAEFY DKQLKVLLSG
     ATFLVTFGNS EKPETMTCRL SNNQRYLFLD GDSHYEIEIV HISTVQILTE GFPPGGGNAR
     ATGMFLQYTV PGTEGVTQLK LTVVEDVTVG RRQAVAWLVA MHKAAKLLYE SRDQ
//
